1H MRS评价长期胰岛素治疗1型糖尿病大鼠海马代谢物的变化

本研究应用质子磁共振波谱（¹H MRS）技术对链脲佐菌素（STZ）诱导的1型糖尿病（T1DM）大鼠及长期胰岛素治疗的T1DM大鼠单侧海马的代谢物进行了分析. 结果发现,与对照组大鼠及胰岛素治疗组大鼠相比,T1DM模型组大鼠空腹血糖显著升高,体重显著降低（p < 0.05）.T1DM模型组肌醇（Ins）、牛磺酸（Tau）与谷氨酸（Glu）浓度较对照组显著升高（p = 0.000、p = 0.003、p = 0.014）.胰岛素治疗组Ins与Tau浓度较T1DM模型组显著降低（p = 0.000、p = 0.010）,与对照组无差别;而Glu、谷氨酸和谷氨酰胺（Glx）浓度较对照组显著升高（p = 0.007、p = 0.042）.本文结果表明T1DM大鼠海马区代谢物Ins浓度与Tau浓度对胰岛素治疗敏感.     

STZ诱导大鼠1型糖尿病进行性脑萎缩的磁共振成像及组织化学研究

1型糖尿病(T1DM)是一种慢性代谢疾病,主要表现为胰岛素分泌量较正常情况下降,会对人体的多个器官和系统造成持续性的损伤．关于糖尿病的横向研究发现糖尿病患者相比于正常人存在着显著的脑萎缩,但关于糖尿病引起的脑萎缩随时间发生进行性改变的研究比较少见．实验采用腹腔注射链脲佐菌素(STZ)来诱导建立大鼠的1型糖尿病模型,运用磁共振成像(MRI)的方法对萎缩的脑区进行定位并在造模后12周和20周两个时间点对脑萎缩的程度进行对比分析,然后运用组织化学染色的方法观察在MRI上出现进行性萎缩的脑区中的神经元所发生的病理改变．MRI的结果表明：STZ诱导的T1DM大鼠相比于正常对照组大鼠出现了显著性的全脑体积、灰质体积和白质体积的萎缩,并且在多个白质脑区和灰质脑区均出现了萎缩程度随着病程的延长而逐渐加重．组织化学染色的结果发现,STZ诱导的T1DM大鼠相对于正常对照组大鼠在体感皮层、运动皮层和海马CA3区,均出现明显的神经元萎缩现象．     

MRI与MRS在肥胖症研究中的应用进展

肥胖症已经成为严重威胁人类健康的主要慢性疾病之一,磁共振成像(MRI)和磁共振波谱(MRS)技术的结合运用,对于评价脂肪组织分布和蓄积程度具有极大的优势.该文总结了近年来MRI与MRS技术在肥胖症研究中的应用进展,并讨论了MRI与MRS技术在肥胖症临床应用及科学研究中的价值.     

基于多尺度计算方法的活体磁共振谱自动相位矫正和代谢物定量分析(英文)

活体多片磁共振谱成像(MRSI)产生大量的波谱数据,因此需要使用自动的谱数据分析方法来获得不同组织代谢产物的定量分布图.然而,活体波谱通常产生严重的谱和基线变形,使得基于曲线拟合的谱定量数据分析方法失效.该文应用多尺度分析(Multiscale)方法自动确定兴趣代谢物在频率空间的谱峰特征(位置和线宽),然后通过叠代运算对该代谢物对应的谱峰进行独立的自动相位矫正和线型拟合.大脑波谱成像的实验结果表明,该方法可以方便、有效的获得代谢产物在大脑的分布,特别适宜于多片磁共振谱成像的代谢产物定量分析.     

1.5 T磁共振化学交换饱和转移成像的影响因素分析

本文探讨1.5 T磁共振化学交换饱和转移（Chemical Exchange Saturation Transfer,CEST）成像的影响因素.通过试管模型和临床病例,采用GE Signa HDe 1.5 T磁共振成像（Magnetic Resonance Imaging,MRI）扫描仪分别进行不同矩阵、激励次数、翻转角、磁化传递翻转角的CEST成像对比分析,以及不同激励次数、磁化传递翻转角的Z谱分析,并从成像组织、成像设备、成像技术等方面对原始图信号、酰胺质子转移（Amide Proton Transfer,APT）信号及Z谱进行分析研究.实验结果表明1.5 T MRI扫描仪的CEST图像信噪比相对较低,且磁场稳定性及均匀度影响了CEST成像的效果.在其他参数不变的情况下,降低采集矩阵和增加激励次数与翻转角可以增加原始图像信噪比.磁化传递翻转角为105°时,CEST成像效果最好.激励次数为2、磁化传递翻转角为105°时,所得数据符合组织Z谱情况.模型Z谱在磁化传递频率为-294~-194 Hz范围可显示30%谷氨酸（Glu）、碘剂（I₃₂₀）、纯水（H₂O）、肌酸（Cr）的信号差异,与H₂O差异最大处在-244~-214 Hz.原始图像信号30% I₃₂₀明显高于Glu、H₂O、Cr,Cr略低于Glu,APT图Cr略低于Glu.25例脑肿瘤的APT图呈高信号、12例脑梗塞的APT图呈低信号,CEST原始图像均可区分病变区域.有12例因采集时间、患者配合情况、环境及室温等影响导致CEST成像的失败.由此得出1.5 T场强下,CEST技术受到成像组织、设备、技术等因素的影响,需要进行多方面优化.在保证磁场稳定性及均匀度的情况下,优化参数的CEST成像和Z谱成像可以区分代谢物及其浓度.     

增强低场下脑功能磁共振成像显著性的研究

实现了基于低场0.35 T磁共振成像系统的大脑功能磁共振成像（functional Magnetic Resonance Imaging,fMRI）的研究. 基于质子密度加权的快速自旋回波(Turbo Spin Echo,TSE)图像,重点研究增强低场fMRI显著性的方法,目的在于提高低场fMRI的可用性. 结果表明：健康受试者在执行手动任务期间,大脑运动区的信号强度变化可以由基于血管外质子信号增强 (Signal Enhancement by Extravascular water Protons,EEP)的对比机制探测. 优化TSE序列参数能提高图像SNR和扫描速度,并在统计分析中增加外在屏蔽图像,可以有效地提高低场下fMRI研究结果的显著性.     

超高场磁共振人体成像应用研究和医学前景

20世纪90年代初,随着第一代超高场磁共振成像仪的投入使用,因其诸多的优点,如更高的检测信噪比、更好的对比度、更强的BOLD效应和更宽的波谱,超高场磁共振成像成为国际医学磁共振领域最热门的研究方向之一.该文以最新一代的7.0 T MRI成像仪为例,简述超高场磁共振人体成像仪的系统结构、研究进展,并展望其在神经科学、认知科学和医学的应用前景.     

超强边缘磁场梯度场下的磁共振成像:STRAFI 实验

磁共振成像（MRI）是一个能够探测样品内部特性的有效检测手段,已被广泛应用于化学、生物研究,以及医疗诊断领域. 自约40年前发展以来, 成像方法的不断发展使得MRI的成像分辨率、实验效率和成像杂核能力得到了很大的改进. 边缘磁场成像（STRAFI）是一种很具潜力的成像方法之一,它利用了超导磁体本身具有的边缘场的强梯度场. 该综述介绍了STRAFI基础,并概括了成像的基本原理、STRAFI的实验理论和方法及其在实际研究中的应用. 由此将比较STRAFI实验相对于传统MRI方法的所具有的优势和多面可行性.     

基于CEST机制的pH成像方法、原理和应用

化学交换饱和转移（Chemical Exchange Saturation Transfer,CEST）技术作为一种新型的磁共振成像（Magnetic Resonance Imaging,MRI）技术.它的原理为溶质池中被激发饱和的质子与游离水中未被饱和的质子间的化学交换,能够引起水质子磁共振信号的下降,从而获得组织内生物分子的相关信息.由于质子间的交换速率k_ex与组织微环境的pH值之间存在直接联系,因而可以通过溶质质子的CEST信号对活体组织进行pH成像.目前用于pH成像的溶质分子既包括内源性游离的蛋白质、多肽分子,还包括一系列的外源性小分子和金属螯合物.通过不同类型的比率法、内源性胺和酰胺浓度-独立检测（Amine and Amide Concentration-independent Detection,AACID）等成像方法,能够获得肾脏、中风脑组织以及肿瘤组织的pH图谱.本文详细总结了2000年以来利用CEST技术进行pH成像方面的研究进展,包括对比剂、成像方法和相关应用,展望了活体组织pH成像的发展趋势和应用前景.     

分子影像新技术——氘代谢波谱及成像的综述与展望

目前常用的分子影像技术主要有正电子发射型断层显像（PET）、质子磁共振波谱（¹H MRS）及成像（¹H MRSI）、化学交换饱和转移（CEST）、超极化¹³C MRSI等.近4年来,氘代谢波谱（DMS）及成像（DMI）作为一种新兴的分子影像技术获得了越来越多的关注,其通过采集注射或口服氘代葡萄糖后的目标组织与正常组织间氘代谢产物的磁共振信号进行组织区分.相比于其他分子影像方法,该影像技术具有无辐射、稳定性好、扫描操作相对简单等优点.本文综述了近年来DMS/DMI技术的研究进展及其意义,归纳总结了其临床应用价值,并对该技术未来的发展和改进方向,以及应用前景进行了展望.     

Noninvasive assessment of abdominal adipose tissues and quantification of hepatic and pancreatic fat fractions in type 2 diabetes mellitus

The purpose of this study was to evaluate adipose tissue distributions and hepatic and pancreatic fat contents using a 6-point Dixon MRI technique in type 2 diabetes mellitus (T2DM), and to assess associations between fat distributions and biochemical markers of insulin resistance. Intra-abdominal MRI was investigated in 14 T2DM patients, 13 age- and sex-matched healthy controls (HC) and 11 young HC using a 3 T Prisma MRI scanner. All T2DM subjects completed a fasting comprehensive metabolic panel, and demographic measurements were taken according to standardized methodologies. We observed excellent correlation (R² = 0.94) between hepatic fat fraction quantified using 6-point Dixon MRI and gold standard MRS, establishing the accuracy and reliability of the Dixon technique. Significantly increased visceral adipose tissue (VAT) volumes were found in T2DM patients compared to age-matched HC (1569.81 ± 670.62 cm³ vs. 1106.60 ± 566.85 cm³, p = .04). We also observed a trend of increasing subcutaneous adipose tissues (SAT), and total abdominal fat (TAT) volumes in T2DM compared to age-matched HC. Hepatic fat fraction percentage (HFF%) was 44.6% higher in T2DM compared to age-matched HC and 64.4% higher compared to young HC. Pancreatic fat fractions in the head and body/tail were higher in T2DM patients compared to both healthy cohorts. We also observed correlations between fat contents of the liver and pancreas in T2DM patients, and association between biochemical markers of T2DM with HFF, indicating a risk for non-alcoholic fatty liver disease among T2DM. In summary, this study provides evidence of T2DM patients having increased liver and pancreatic fat, as well as increased adipose tissues.     

Assessment of the metabolic profile in Type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy

The metabolic changes in the brain of patients affected with Type 2 diabetes mellitus (DM) alone, both Type 2 DM and hypothyroidism and hypothyroidism only were investigated using proton magnetic resonance spectroscopy ((1)H MRS). Single-voxel spectroscopy was carried out in right and left frontal lobe white matter, left parietal white matter and left occipital gray matter. Choline (Cho)/creatine (Cr) value was found to be increased in the left occipital gray matter of the subjects affected with Type 2 DM and both Type 2 DM and hypothyroidism as compared to controls. No significant change in the Cho/Cr value in the occipital gray matter was observed in hypothyroid subjects as compared to controls. However, they showed an increased level of Cho/Cr in the frontal white matter. High Cho is associated with altered membrane phospholipid metabolism. The high Cho in frontal white matter in hypothyroids and occipital gray matter in diabetic patients suggests that, though both the diseases are endocrine disorders, they differ from each other in terms of regional brain metabolite changes.     

Quantitative combination of volumetric MR imaging and MR spectroscopy data for the discrimination of meningiomas from metastatic brain tumors by means of pattern recognition

The analysis of information derived from magnetic resonance imaging (MRI) and spectroscopy (MRS) has been identified as an important indicator for discriminating among different brain pathologies. The purpose of this study was to investigate the efficiency of the combination of textural MRI features and MRS metabolite ratios by means of a pattern recognition system in the task of discriminating between meningiomas and metastatic brain tumors. The data set consisted of 40 brain MR image series and their corresponding spectral data obtained from patients with verified tumors. The pattern recognition system was designed employing the support vector machines classifier with radial basis function kernel; the system was evaluated using an external cross validation process to render results indicative of the generalization performance to “unknown” cases. The combination of MR textural and spectroscopic features resulted in 92.15% overall accuracy in discriminating meningiomas from metastatic brain tumors. The fusion of the information derived from MRI and MRS data might be helpful in providing clinicians a useful second opinion tool for accurate characterization of brain tumors.     

Development of the time course for processing conflict: an event-related potentials study with 4 year olds and adults

Background

The neurological complications of HIV infection remain poorly understood. Clinically, in vivo ¹H magnetic resonance spectroscopy (MRS) demonstrates brain injury caused by HIV infection even when the MRI is normal. Our goal was to undertsand the dynamics of cerebral injury by performing a longitudinal in vivo ¹H MRS study of the SIV/macaque model of neuroAIDS.

Results

Eight rhesus macaques were infected with SIVmac251 and serially imaged with MRI and ¹H MRS to terminal AIDS or the endpoint of 2 years. During acute infection, there were stereotypical brain MRS changes, dominated by a significant elevation of the Cho/Cr ratio in the frontal cortex. Subsequently, brain metabolic patterns diverged between animals. There was an elevation of basal ganglia Cho/Cr four weeks post-inoculation in 2 animals that developed SIV encephalitis (p = 0.022). Metabolite ratios averaged across all 8 animals were not significantly different from baseline at any time point after 2 weeks post inoculation. However, linear regression analysis on all 8 animals revealed a positive correlation between a change in frontal lobe Cho/Cr and plasma viral load (P < 0.001, R = 0.80), and a negative correlation between NAA/Cr in the basal ganglia and the plasma viral load (P < 0.02, R = -0.73). No MRI abnormalities were detected at any time.

Conclusions

After infection with SIV, macaque brain metabolism changes in a complex manner that is dependent on brain region, host factors and viral load. An elevation of basal ganglia Cho/Cr 4 weeks after SIV infection may be marker of a propensity to develop SIV encephalitis. Elevations of Cho/Cr, often observed in CNS inflammation, were associated with increased plasma viral load during acute and chronic infection. Evidence of neuronal injury in the basal ganglia was associated with increased plasma viral load in the chronic stage of infection. These observations support the use of drugs capable of controlling the viral replication and trafficking of virus into the CNS, and may help explain the reduction in incidence of HIV-associated dementia in the era of HAART despite the inability of most of those drugs to effectively enter the CNS.     

Brain metabolite alterations demonstrated by proton magnetic resonance spectroscopy in diabetic patients with retinopathy

Due to the homology between retinal and cerebral microvasculatures, retinopathy is a putative indicator of cerebrovascular dysfunction. This study aimed to detect metabolite changes of brain tissue in type 2 diabetes mellitus (T2DM) patients with diabetic retinopathy (DR) using proton magnetic resonance spectroscopy (¹H-MRS). Twenty-nine T2DM patients with DR (DR group), thirty T2DM patients without DR (DM group) and thirty normal controls (NC group) were involved in this study. Single-voxel ¹H-MRS (TR: 2000 ms, TE: 30 ms) was performed at 3.0 T MRI/MRS imager in cerebral left frontal white matter, left lenticular nucleus, and left optic radiation. Our data showed that NAA/Cr ratios of the DR group were significantly lower than those of the DM group in the frontal white matter and optic radiation. In the lenticular nucleus, MI/Cr ratios were significantly higher in the DM group than those in the NC group, while MI/Cr ratios were significantly lower in the DR group than those in the DM group. In the frontal white matter, NAA/Cho ratios were found to be decreased in the DR group as compared to the NC group. Additionally, our finding indicated that NAA/Cr ratios were negatively associated with DR severity in both the frontal white matter and optic radiation. A decrease in NAA indicated neuronal loss and the likely explanation for a decrease in MI was glial loss. In conclusion, we inferred that cerebral neurons and glia cells were damaged in patients with DR. Our data support that DR is associated with brain tissue damage.     

Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T

OBJECTIVES: The objectives of this study were to develop protocols that measure abdominal fat and calf muscle lipids with magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS), respectively, at 3 T and to examine the correlation between these parameters and insulin sensitivity. MATERIALS AND METHODS: Ten nondiabetic subjects [five insulin-sensitive (IS) subjects and five insulin-resistant (IR) subjects] were scanned at 3 T. Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were segmented semiautomatically from abdominal imaging. Intramyocellular lipids (IMCL) in calf muscles were quantified with single-voxel MRS in both soleus and tibialis anterior muscles and with magnetic resonance spectroscopic imaging (MRSI). RESULTS: The average coefficient of variation (CV) of VAT/(VAT+SAT) was 5.2%. The interoperator CV was 1.1% and 5.3% for SAT and VAT estimates, respectively. The CV of IMCL was 13.7% in soleus, 11.9% in tibialis anterior and 2.9% with MRSI. IMCL based on MRSI (3.8+/-1.2%) were significantly inversely correlated with glucose disposal rate, as measured by a hyperinsulinemic-euglycemic clamp. VAT volume correlated significantly with IMCL. IMCL based on MRSI for IR subjects was significantly greater than that for IS subjects (4.5+/-0.9% vs. 2.8+/-0.5%, P=.02). CONCLUSION: MRI and MRS techniques provide a robust noninvasive measurement of abdominal fat and muscle IMCL, which are correlated with insulin action in humans.     

3D phase encoding 1H spectroscopic imaging of human brain.

A three-dimensional (3D) phase-encoding proton spectroscopic imaging method is presented for a whole body MRI/MRS system. Metabolite images at 2 T of choline, creatine, and N-acetyl aspartate (NAA) of normal brain were obtained with a spatial resolution of 1.5 cc. With PRESS volume preselection and outer volume suppression pulses, brain regions close to the skull could be studied without significant contamination by lipid and water signals.